|Aglaia Oncology Funds||Bilthoven, Netherlands, Utrecht|
|Ashoka India Equity Investment Trust||-|
|CJM Ventures||Alabama, Five Points, United States|
|CNF Ventures||Ann Arbor, Michigan, United States|
|GII Tech Ventures||Dubai, United Arab Emirates|
|ICONIUM||Italy, Lombardy, Milan|
|Kismet Capital Group (KCG)||Moscow, Moscow, Russia|
|Pleiade Capital||Canada, Montréal, Quebec|
|Point Field Partners||-|
|Randstad||Netherlands, Noord-Holland, North Holland|
|Rongming Capital Management||Beijing, Beijing, China|
|Schechter Private Capital||-|
|Segal Family Foundation||New Jersey, United States, Watchung|
|SherpaShare||California, Menlo Park, United States|
|SmartCap||Estonia, Harjumaa, Tallinn|
|YI Technology||California, Sunnyvale, United States|
|$170M||07 Nov 2022||Warren, Ohio, United States|
|$15M||01 Nov 2021||Nanjing, Jiangsu, China|
|$7M||20 Dec 2018||Fukuoka Prefecture|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.